A genetic medicines customer has selected the company’s binders for commercial development of the customer’s product. Aptamer Group announced on Nov. 7, 2024 that one of its customers has advanced use ...

The merger agreement is valued at approximately $1.1 billion. Avid Bioservices, a biologics contract development and manufacturing organization (CDMO), announced on Nov. 6, 2024 that it has entered ...

The complexities of tech transfer may be overcome by data-driven approaches, digital tools, and effective communication.

Recent hurricanes in the US close Baxter plant, shining a spotlight on supply chain fragility again.

The product license holder must have a supplier oversight system in place, says Siegfried Schmitt, PhD, vice president, ...

The system is Hapman’s first major product launch since 2008, following a year of intensive R&D that builds upon the company’s eight decades of tubular drag conveyor expertise.

In this episode of Drug Digest, industry experts discuss the ongoing development of automating biomanufacturing processes, including its challenges and practical applications.

Alec McChesney (BD Director, SCORR Marketing) discusses goal setting and alignment between life sciences marketing and business development teams. Alec McChesney sat down with Pharmaceutical ...

Find out more about key trends shaping solid dosage drug development and manufacturing and the changing demands impacting the market. Furthermore, gain a greater understanding about how coating design ...

In this podcast episode, we discuss trends in dosage forms, specifically oral solid dosage, as viewed by five industry experts who recently exhibited at CPHI Milan. Michelle Logan is vice president, ...

The company will be expanding its quality control testing capabilities at its San Diego, Calif. biologics development and manufacturing site. Abzena, an end-to-end contract development and ...